Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | PALB2 |
| Variant | T1030I |
| Impact List | missense |
| Protein Effect | loss of function |
| Gene Variant Descriptions | PALB2 T1030I lies within WD repeat 4 of the Palb2 protein (UniProt.org). T1030I confers a loss of function to the Palb2 protein as demonstrated by reduced Rad51 and Rad51c binding in in vitro assays (PMID: 24141787), decreased protein stability (PMID: 24141787, PMID: 31757951), reduced Rad51 foci formation, loss of Brca2 binding, and aberrant cytoplasmic localization (PMID: 31586400), and impaired homology-directed DNA repair activity compared to wild-type Palb2 in cultured cells (PMID: 31586400, PMID: 31636395, PMID: 31757951). |
| Associated Drug Resistance | |
| Category Variants Paths |
PALB2 mutant PALB2 inact mut PALB2 T1030I |
| Transcript | NM_024675.4 |
| gDNA | chr16:g.23621386G>A |
| cDNA | c.3089C>T |
| Protein | p.T1030I |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_017023673 | chr16:g.23621386G>A | c.3089C>T | p.T1030I | RefSeq | GRCh38/hg38 |
| NM_024675.3 | chr16:g.23621386G>A | c.3089C>T | p.T1030I | RefSeq | GRCh38/hg38 |
| XM_017023673.2 | chr16:g.23621386G>A | c.3089C>T | p.T1030I | RefSeq | GRCh38/hg38 |
| NM_001407299.1 | chr16:g.23621386G>A | c.3089C>T | p.T1030I | RefSeq | GRCh38/hg38 |
| NM_024675 | chr16:g.23621386G>A | c.3089C>T | p.T1030I | RefSeq | GRCh38/hg38 |
| XM_017023672.2 | chr16:g.23621386G>A | c.3089C>T | p.T1030I | RefSeq | GRCh38/hg38 |
| NM_001407301.1 | chr16:g.23621386G>A | c.3089C>T | p.T1030I | RefSeq | GRCh38/hg38 |
| NM_024675.4 | chr16:g.23621386G>A | c.3089C>T | p.T1030I | RefSeq | GRCh38/hg38 |
| XM_017023672 | chr16:g.23621386G>A | c.3089C>T | p.T1030I | RefSeq | GRCh38/hg38 |
| Molecular Profile | Protein Effect | Treatment Approaches |
|---|---|---|
| PALB2 T1030I | loss of function | PARP Inhibitor (Pan) |